Ipratropium Bromide/Salbutamol-Induced Acute Urinary Retention as a Result of Medication Error: A Case Report and Review of Cases in the Literature [0.03%]
异丙托溴铵/沙丁胺醇导致的药物误用致急性尿潴留1例及相关文献复习
Mohammed Abdullah Kubas,Fahmi Y Al-Ashwal,Orwa Khaled Babattah et al.
Mohammed Abdullah Kubas et al.
Medication errors have the potential to cause serious toxicity and hospitalization. This case report describes a 25-year woman who suffered serious side effects and was hospitalized after receiving intravenous ipratropium bromide/salbutam...
Takla R Anis,John Meher
Takla R Anis
Allopurinol is a commonly used medication that lowers uric acid production which is essential for gout treatment and prevention. Although many patients tolerate allopurinol therapy without severe complications; Stevens-Johnson Syndrome (SJS...
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review [0.03%]
信使核糖核酸(mRNA)疫苗及其递送系统的最新研究进展综述
Wubetu Yihunie,Getinet Nibret,Yibeltal Aschale
Wubetu Yihunie
Messenger ribonucleic acid (mRNA) was found as the intermediary that transfers genetic information from DNA to ribosomes for protein synthesis in 1961. The emergency use authorization of the two covid-19 mRNA vaccines, BNT162b2 and mRNA-127...
Recommendations of Gentamicin Dose Based on Different Pharmacokinetic/Pharmacodynamic Targets for Intensive Care Adult Patients: A Redefining Approach [0.03%]
基于不同药动/药效学目标的重症成人患者庆大霉素剂量建议：重新定义的方法
Mohammad Yaseen Abbasi,Weerachai Chaijamorn,Kamonthip Wiwattanawongsa et al.
Mohammad Yaseen Abbasi et al.
Background: In addition to the maximum plasma concentration (Cmax) to the minimum inhibitory concentration (MIC) ratio, the 24-hour area under the concentration-time curve (AUC24h) to MIC has recently been suggested as ph...
Erratum: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain [Corrigendum] [0.03%]
姜黄新型低剂量提取物配方在慢性膝关节疼痛的健康成人中疗效和安全性的多中心、随机、双盲、安慰剂对照试验的勘误表
[This corrects the article DOI: 10.2147/CPAA.S307464.]. © 2023 Thanawala et al.
Gaurav P Patel,Susan A Smith,Michelle Romej et al.
Gaurav P Patel et al.
Hypotension during kidney transplantation can be common. Vasopressor use during these procedures is often avoided, with a fear of decreasing renal perfusion in the transplanted kidney. However, adequate perfusion for the rest of the body is...
Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus [0.03%]
托格列净和安立格列汀及其联用对2型糖尿病患者糖代谢及动脉粥样硬化相关标志物的影响
Shosaku Nomura,Akira Shouzu,Takehito Taniura et al.
Shosaku Nomura et al.
Purpose: In people with type 2 diabetes mellitus (T2DM), both glucose metabolism abnormalities and atherosclerosis risk are significant concerns. This study aims to investigate the effects of the sodium-glucose cotranspor...
Somaya Koraysh,Junais Koleri,Maisa Ali
Somaya Koraysh
Cefepime is a fourth-generation cephalosporin utilized in treatment of multiple Gram-negative and -positive infections. The current report presents a case of 50-year-old man admitted with epidural abscess who developed neutropenia after pro...
Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults [0.03%]
RTS,S联合AS01和AS02佐剂系统安全性系统评价：随机对照试验的受试者数据报告
Wubetu Yihunie,Bekalu Kebede,Bantayehu Addis Tegegne et al.
Wubetu Yihunie et al.
Background: Emergence of antimalarial drugs and insecticides resistance alarms scientists to develop a safe and effective malaria vaccine. A pre-erythrocytic malaria vaccine called RTS,S has made great strides. ...
A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects [0.03%]
一项在轻度、中度或重度肝功能不全受试者与健康受试者中评估伊沙佐米药代动力学的I期多中心开放标签研究
Yiming Cheng,Ying Ye,Allison Gaudy et al.
Yiming Cheng et al.
Introduction: Iberdomide, a novel cereblon modulator (CELMoD®), is currently under clinical investigation for hematology indications. To evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of iberdo...